[Immunomodulation and systematic enzymotherapy during surgical treatment of the duodenal ulcers].
The aim of our investigation was to study the influence of the systematic enzymotherapy on the results of surgical treatment of patients with duodenal ulcers. The immunological investigation was conducted on 77 patients with duodenal ulcers. The obtained results reveal the changes of immunological indexes in patients with duodenal ulcers. The process of rehabilitation with immunomodulative and enzymatic therapy after surgical treatment is analyzed and described.
Kuliev
T A
TA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D003131:Combined Modality Therapy; D004381:Duodenal Ulcer / Q000276:immunology* / Q000601:surgery*; D020536:Enzyme Activators / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood / Q000276:immunology; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D007075:Immunoglobulin M / Q000097:blood / Q000276:immunology; D056747:Immunomodulation; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009113:Muramidase / Q000097:blood; D011300:Preoperative Care; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D014629:Vagotomy, Proximal Gastric / Q000379:methods*
D000276:Adjuvants, Immunologic; D020536:Enzyme Activators; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007978:Levamisole; D009113:Muramidase